Insilico Study of Type II Diabetes and Effective Drugs: a Bioinformatics Study of Diabetes Genes - Satyavani Guttula - Libros - LAP LAMBERT Academic Publishing - 9783848483204 - 24 de julio de 2012
En caso de que portada y título no coincidan, el título será el correcto

Insilico Study of Type II Diabetes and Effective Drugs: a Bioinformatics Study of Diabetes Genes


Recibe un correo electrónico cuando el artículo esté disponible
¿Tienes un perfil? Iniciar sesión
Recibe notificaciones sobre nuevos lanzamientos de Satyavani Guttula
Añadir a tu lista de deseos de iMusic

Aún no valorado

Diabetes is an important and increasingly common global health problem. The World Health Organization has estimated that about 170 million people currently have diabetes worldwide. Environmental factors such as obesity, a diet high in sugar, and a sedentary lifestyle are all risk factors for developing Type 2 diabetes. This book provides the basic knowledge to analyze Microarray data of diebetes. Clustering is done to the genes which are more expressed in Type II diabetes. Phylogenetic analysis is done on the basis of the sequence similarity by which the rate of expression is also similar. Two proteins Beliverdine and Uroporphyrinogen are taken and eight antidiabetic drugs such as Acarbose, Gliquidone, Metformin, Miglitol, Mitiglinide, Pioglitazone, Sitagliptin, Voglibose. These drugs are used as ligands. The two receptors are subjected to docking with eight ligands. ACARBOSE is determined as most efficient drug.

Medios de comunicación Libros     Paperback Book   (Libro con tapa blanda y lomo encolado)
Publicado 24 de julio de 2012
ISBN13 9783848483204
Editores LAP LAMBERT Academic Publishing
Páginas 128
Dimensiones 150 × 220 × 10 mm   ·   199 g
Lengua Inglés